4584 · Kidswell Bio Corporation · Financials
Market Cap
6.90B JPY
Shares
49.64M
Volume · Nov 12
434K
Avg daily vol (3M)
291.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
6.59B
+29.7%
FY2026
Net Income
-413.99M
-1858.3%
FY2026
Gross Margin
26.52%
-5.8pp
FY2026
Operating Margin
-2.1%
-2.6pp
FY2026
Operating Cash Flow
-1.1B
-217%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 6.59B | 5.08B | 2.43B | 2.78B | 1.57B |
| JPY | 4.84B | 3.44B | 1.39B | 1.25B | 550.36M |
| JPY | 1.75B | 1.64B | 1.04B | 1.53B | 1.02B |
| JPY | -138.51M | 27.88M | -1.34B | -550.93M | -919.12M |
| JPY | -402.93M | 72.87M | -1.42B | -656.22M | -533.76M |
| JPY | 11.07M | 94.01M | 1.55M | 1.21M | 1.5M |
| JPY | -413.99M | -21.14M | -1.42B | -657.43M | -535.26M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.